ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
6.70
+0.44 (7.03%)
At close: Nov 18, 2026, 4:00 PM EST
6.70
0.00 (0.00%)
Pre-market: Nov 19, 2026, 8:37 AM EST
ImmunityBio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 45.08 | 88.33 | 143.43 | 265.45 | 104.64 | 181.1 |
Short-Term Investments | 289.25 | 154.48 | 6.38 | 1.01 | 2.54 | 136.02 |
Cash & Short-Term Investments | 334.33 | 242.82 | 149.81 | 266.46 | 107.18 | 317.12 |
Cash Growth | 29.68% | 62.09% | -43.78% | 148.60% | -66.20% | 230.12% |
Accounts Receivable | 53.6 | 42.57 | 2.36 | - | - | - |
Other Receivables | 0.01 | 0.05 | 0.29 | 3.17 | 1.89 | 1.33 |
Receivables | 53.61 | 42.62 | 2.65 | 3.17 | 1.89 | 1.33 |
Inventory | 0.01 | 0.91 | 8.27 | - | 2.16 | - |
Prepaid Expenses | 30.84 | 16.85 | 16.73 | 13.98 | 14.74 | 12.25 |
Other Current Assets | - | 11.68 | 7.12 | 10.47 | 14.6 | 3.65 |
Total Current Assets | 418.79 | 314.88 | 184.59 | 294.08 | 140.58 | 334.35 |
Property, Plant & Equipment | 142.89 | 147.55 | 170.46 | 182.68 | 189.58 | 119.17 |
Long-Term Investments | - | 14.21 | 0.7 | 0.89 | 0.84 | 7.6 |
Goodwill | - | 0.91 | 0.91 | - | - | - |
Other Intangible Assets | 10.76 | 13.04 | 15.02 | 17.09 | 20 | 1.42 |
Other Long-Term Assets | 36.96 | 3.94 | 4.13 | 2.82 | 4.73 | - |
Total Assets | 609.39 | 501.9 | 382.93 | 504.45 | 362.36 | 468.91 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 13.84 | 6.98 | 6.73 | 9.2 | 21.02 | 11.42 |
Accrued Expenses | 75.95 | 42.01 | 38.28 | 39.53 | 34.23 | 33.94 |
Short-Term Debt | - | 1.75 | 1.25 | 1.48 | 433.32 | 301.83 |
Current Portion of Leases | 7.37 | 7.59 | 7.47 | 5.31 | 2.73 | 3.01 |
Other Current Liabilities | 0.93 | 3.42 | 1.22 | 2.77 | 9.57 | 18.8 |
Total Current Liabilities | 98.09 | 61.75 | 54.94 | 58.28 | 500.86 | 369 |
Long-Term Debt | 1,261 | 801.71 | 746.28 | 836.95 | 241.27 | 306.35 |
Long-Term Leases | 27.45 | 33.67 | 34.82 | 39.94 | 48.02 | 37.07 |
Other Long-Term Liabilities | 368.02 | 104.34 | 35.01 | 155.21 | 22.03 | 0.41 |
Total Liabilities | 1,755 | 1,001 | 871.06 | 1,090 | 812.18 | 712.82 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.11 | 0.1 | 0.09 | 0.07 | 0.04 | 0.04 |
Additional Paid-In Capital | 3,601 | 3,197 | 2,885 | 2,375 | 1,931 | 1,720 |
Retained Earnings | -4,774 | -3,727 | -3,375 | -2,962 | -2,378 | -1,962 |
Comprehensive Income & Other | 26.88 | 28.96 | 1.2 | 0.01 | 0.18 | 0 |
Total Common Equity | -1,146 | -500.47 | -489.1 | -586.99 | -447.33 | -242.17 |
Minority Interest | 0.85 | 0.9 | 0.97 | 1.05 | -2.49 | -1.74 |
Shareholders' Equity | -1,145 | -499.57 | -488.13 | -585.94 | -449.82 | -243.91 |
Total Liabilities & Equity | 609.39 | 501.9 | 382.93 | 504.45 | 362.36 | 468.91 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,296 | 844.72 | 789.82 | 883.68 | 725.33 | 648.26 |
Net Cash (Debt) | -961.77 | -601.9 | -640.01 | -616.32 | -617.31 | -330.32 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.93 | -0.65 | -0.91 | -1.21 | -1.54 | -0.85 |
Filing Date Shares Outstanding | 1,064 | 1,028 | 853.44 | 673.95 | 435.84 | 397.91 |
Total Common Shares Outstanding | 1,064 | 1,012 | 852.9 | 670.87 | 421.57 | 397.83 |
Working Capital | 320.7 | 253.12 | 129.64 | 235.8 | -360.28 | -34.65 |
Book Value Per Share | -1.08 | -0.49 | -0.57 | -0.87 | -1.06 | -0.61 |
Tangible Book Value | -1,157 | -514.42 | -505.03 | -604.08 | -467.33 | -243.59 |
Tangible Book Value Per Share | -1.09 | -0.51 | -0.59 | -0.90 | -1.11 | -0.61 |
Machinery | - | 65.13 | 75.44 | 71.8 | 69.85 | 55.34 |
Construction In Progress | - | 86.43 | 86.42 | 84.44 | 72.69 | 16.58 |
Leasehold Improvements | - | 73.14 | 73.13 | 72.55 | 68.71 | 62.48 |